Orphan drugs for the pathogenetic treatment of rаre diseases in the drug registry

by S. A. Mishinova
Published 2019-04-01

Health-economic analysis of tocilizumab in patients with rheumatoid arthritis and systemic juvenile arthritis

by A. S. Kolbin, A. A. Kurylev, S. A. Mishinova, Yu. E. Balykina, M. A. Proskurin
Published 2020-05-01

The social-economic burden of spinal muscular atrophy in Russia

by A. S. Kolbin, D. V. Vlodavets, A. A. Kurylev, Yu. Ye. Balykina, M. A. Proskurin, S. A. Mishinova, O. Yu. Germanenko, N. Yu. Kolbina
Published 2021-02-01